FVC (% predicted) Change from baseline · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
1 finding from 1 review
Intervention not reported
Core temperature at 30 minutes after induction degrees Celsius · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Core temperature at 60 minutes after induction degrees Celsius · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Core temperature at 90 minutes after induction degrees Celsius · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Core temperature at 120 minutes after induction degrees Celsius · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Core temperature at end of procedure/arrival to PACU ‐ simple design degrees Celsius · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Patient‐reported outcome: shivering various tools · patients with inadvertent perioperative hypothermia
The intervention probably leads to lower patient‐reported outcome: shivering various tools (moderate certainty).
1 finding from 1 review
Intervention not reported
Temperature at end of procedure /arrival in PACU · patients with inadvertent perioperative hypothermia
1 finding from 1 review
Intervention not reported
Event rate of shivering various tools · patients with inadvertent perioperative hypothermia
The intervention showed no clear difference in event rate of shivering various tools (low certainty).
1 finding from 1 review
Change in disability after 4 weeks disability grade change. Scale from: 0 to 10. · patients with Guillain‐Barré syndrome
1 finding from 1 review
Number improved by 1 or more disability grades after 4 weeks · patients with Guillain‐Barré syndrome
IVIg showed no clear difference in number improved by 1 or more disability grades after 4 weeks compared with PE (moderate certainty).
1 finding from 1 review
Dead or disabled after 12 months (48 weeks) · patients with Guillain‐Barré syndrome
IVIg showed no clear difference in dead or disabled after 12 months (48 weeks) compared with PE (low certainty).
1 finding from 1 review
Relapse or treatment‐related fluctuation · patients with Guillain‐Barré syndrome
IVIg showed no clear difference in relapse or treatment‐related fluctuation compared with PE (low certainty).
1 finding from 1 review
Patients in whom treatment was discontinued · patients with Guillain‐Barré syndrome
IVIg leads to lower participants in whom treatment was discontinued compared with PE (high certainty).
1 finding from 1 review
Number of patients with adverse events attributed to treatment · patients with Guillain‐Barré syndrome
IVIg showed no clear difference in number of participants with adverse events attributed to treatment compared with PE (moderate certainty).
1 finding from 1 review
Number of patients with postoperative nausea and vomiting (postoperative care unit) · paediatric
Induction and maintenance: sevoflurane + nitrous oxide (N2O) may leads to higher postoperative nausea and vomiting compared with propofol + N2O (low certainty).
1 finding from 1 review
Postoperative behavioural disturbances Different scales · paediatric
It is very uncertain whether induction and maintenance: sevoflurane + nitrous oxide (N2O) changes postoperative behavioural disturbances Different scales compared with propofol + N2O (very low certainty).
1 finding from 1 review
Intraoperative and postoperative respiratory and cardiovascular complications · paediatric
It is very uncertain whether induction and maintenance: sevoflurane + nitrous oxide (N2O) changes intraoperative and postoperative respiratory and cardiovascular… compared with propofol + N2O (very low certainty).
1 finding from 1 review
Change in Hamilton Depression Scale scores Scale of Hamilton Depression scores · patients with depressive patients receiving MECT
1 finding from 1 review
EEG seizure duration EEG detection and measurement · patients with depressive patients receiving MECT
1 finding from 1 review